v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF MEZZANINE EQUITY AND STOCKHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Series B Convertible Perpetual Preferred Stock
Common stock
Additional paid-in capital
Accumulated other comprehensive loss
Accumulated deficit
Beginning balance (in shares) at Dec. 31, 2024     173,566      
Beginning balance at Dec. 31, 2024 $ 180,449   $ 174 $ 813,573 $ 78 $ (633,376)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of Common Stock (in shares)     4,091      
Issuance of Common Stock 33,152   $ 4 33,148    
Warrants exercised (in shares)     1,511      
Warrants exercised 14,217   $ 1 14,216    
Share repurchase (in shares)     (187)      
Share repurchase (1,697)     (1,697)    
Equity-based compensation (in shares)     554      
Equity-based compensation 3,354   $ 1 3,353    
Cumulative translation adjustment (94)       (94)  
Net Income (Loss) 8,832         8,832
Ending balance (in shares) at Mar. 31, 2025     179,535      
Ending balance at Mar. 31, 2025 $ 238,213   $ 180 862,593 (16) (624,544)
Beginning balance (in shares) at Dec. 31, 2025 180,281   180,281      
Beginning balance at Dec. 31, 2025 $ 45,887   $ 180 861,953 (305) (815,941)
Beginning balance (in shares) at Dec. 31, 2025 300 300        
Beginning balance at Dec. 31, 2025 $ 304,701 $ 304,701        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Accrued dividends on Series B Convertible Perpetual Preferred Stock   5,313        
Redemption of Series B Convertible Perpetual Preferred Stock   $ (10)        
Accrued dividends on Series B Convertible Perpetual Preferred Stock (5,313)     (5,313)    
Redemption of Series B Convertible Perpetual Preferred Stock (in shares)     1      
Redemption of Series B Convertible Perpetual Preferred Stock 10     10    
Warrants exercised (in shares)     20      
Warrants exercised 230     230    
Share repurchase (in shares)     (295)      
Share repurchase (2,223)     (2,223)    
Equity-based compensation (in shares)     834      
Equity-based compensation 2,544   $ 1 2,543    
Unrealized loss on available for sale debt securities (16)       (16)  
Cumulative translation adjustment (254)       (254)  
Net Income (Loss) $ (33,441)         (33,441)
Ending balance (in shares) at Mar. 31, 2026 300 300        
Ending balance at Mar. 31, 2026 $ 310,004 $ 310,004        
Ending balance (in shares) at Mar. 31, 2026 180,841   180,841      
Ending balance at Mar. 31, 2026 $ 7,424   $ 181 $ 857,200 $ (575) $ (849,382)